62nd ASH Annual Meeting and Exposition: 901. Health Services Research

Oral and Poster Abstracts
Oral

Anemias, antibodies, autoimmune disorders, Biological, Diseases, Bleeding and Clotting, Non-Biological, Therapies, Thrombosis, iron deficiency, Pregnancy, Immune Disorders, Platelet Disorders, Study Population, Clinically relevant, Thrombocytopenias, Quality Improvement , TTP, VWD

Moderators:

Satheesh Chonat, MD, Cincinnati Children's Hospital and Adam Cuker, MD, MS, University of Pennsylvania

Disclosures:

Cuker: Synergy CRO: Consultancy; Spark Therapeutics: Research Funding; Takeda: Research Funding; Novartis: Research Funding; Novo Nordisk: Research Funding; Pfizer: Research Funding; Sanofi: Research Funding; Bayer: Research Funding; Alexion: Research Funding.

12:00 PM

424

Suboptimal Screening for Iron Deficiency in Pregnancy in a High Resource Setting

Jennifer Teichman, MD¹, Michelle Sholzberg, MDCM, FRCPC, MSc^2,3,4,5, Rosane Nisenbaum, PhD⁶^* and Andrea Lausman, MD, FRCSC⁷^*

¹Department of Medicine, University of Toronto, Toronto, ON, Canada
²Department of Laboratory Medicine and Pathobiology, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada
³University of Toronto, Toronto, ON, Canada
⁴Division of Hematology-Oncology, Department of Medicine, St. Michael's Hospital, Toronto, ON, Canada
⁵Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, ON, Canada
⁶Li Ka Shing Knowledge Institute, Centre for Urban Health Solutions, St. Michael's Hospital, Toronto, ON, Canada
⁷Department of Obstetrics & Gynecology, St. Michael’s Hospital, Toronto, ON, Canada

12:15 PM

425

E-Iron: Rethinking the Way We Deliver Intravenous Iron. Report of a Pilot Telemedicine Initiative

Mark Chaitowitz, MD¹ and Sharon Rikin, MD, MS²^*

¹Hematology/Oncology, Montefiore, New York, NY
²Montefiore Medical Center, Bronx, NY

12:30 PM

426

Effect of Sutimlimab Treatment on Healthcare Resource Utilization in Patients with Cold Agglutinin Disease

Alexander Röth, MD¹, Sophie Guillonneau²^*, Nadege Narcisse³^*, Paulo Carita²^*, Jun Su⁴^* and Florence Joly²^*

¹University Hospital Essen, Essen, Germany
²Sanofi, Chilly-Mazarin, France
³Aixial, Boulogne-Billancourt, France
⁴Sanofi, Cambridge, MA

12:45 PM

427

Cost Effectiveness of Caplacizumab in Acquired Thrombotic Thrombocytopenic Purpura

George Goshua, MD¹, Pranay Sinha, MD²^*, Jeanne E. Hendrickson, MD³, Christopher A. Tormey, MD⁴, Pavan Bendapudi, MD^5,6 and Alfred Ian Lee, MD, PhD⁷

¹Section of Hematology, Yale University School of Medicine, New Haven, CT
²Infectious Diseases, Boston Medical Center, Boston, MA
³Department of Laboratory Medicine, Yale University, Guilford, CT
⁴Department of Laboratory Medicine, Yale University School of Medicine, New Haven, CT
⁵Division of Hematology and Blood Transfusion Service, Massachusetts General Hospital, Boston, MA
⁶Division of Thrombosis and Hemostasis, Beth Israel Deaconess Medical Center, Cambridge, MA
⁷Section of Hematology, Department of Internal Medicine, Yale University School of Medicine and Yale Cancer Center, New Haven, CT

1:00 PM

428

Burden of Illness Among Medicare and Non-Medicare Populations with Acquired Thrombotic Thrombocytopenic Purpura, 2010-2018

Laurence Pollissard¹^*, Anne Shah²^*, Rajeshwari Punekar³^*, Allison Petrilla²^* and Huy P Pham, MD, MPH⁴^*

¹Sanofi, Chilly-Mazarin, France
²Avalere Health, Washington, DC
³Sanofi, Cambridge, MA
⁴Department of Pathology, University of Southern California, Los Angeles, CA

1:15 PM

429

Deep Vein Thrombosis Diagnosis with D-Dimer Adjusted to Clinical Probability

Kerstin de Wit, MBChB, MDm MSc¹^*, Sameer Papira²^*, Sam Schulman, MD, PhD, FRCPC³, Fred Spencer, MD, FRCP⁴^*, Sangita Sharma⁵^*, Marc Afilalo⁶^*, Susan Kahn, MD⁷, Gregoire Le Gal, MD, PhD⁸, Sudeep P Shivakumar, MD, BSc⁹^*, Shannon M. Bates, MD, FRCPC, MSc¹⁰, Cynthia M. Wu, MD, FRCPC¹¹, Alejandro Lazo-Langner, MD, MSc¹², Frederick D’Aragon, MD¹³^*, Jean-Francois Deshaies¹⁴^*, Luciana Spadafora¹⁰^*, Jim Julian¹⁵^* and Clive Kearon, MB, PhD¹⁰

¹Dr., Hamilton, Canada
²McMaster University, Hamilton, ON, CAN
³Department of Medicine, Division of Hematology and Thromboembolism, McMaster University, Hamilton, ON, Canada
⁴Department of Medicine, McMaster University, Hamilton, ON, CAN
⁵McMaster University, Hamilton, Canada
⁶McGill University, Montreal, Canada
⁷Center for Clinical Epidemiology and Community Studies, Montreal, QC, Canada
⁸Ottawa Hospital Research Institute, Ottawa, ON, Canada
⁹Division of Hematology, Dalhousie University, Halifax, NS, Canada
¹⁰McMaster University, Hamilton, ON, Canada
¹¹Department of Medicine, University of Alberta, Edmonton, AB, Canada
¹²Division of Hematology, Department of Medicine, London Health Sciences Centre, London, ON, Canada
¹³Université de Sherbrook, Sherborrk, Canada
¹⁴Université de Sherbrook, Sherbrook, Canada
¹⁵McMaster University, Hamilton, On, CAN

See more of: Oral and Poster Abstracts

<< Previous Session | Next Session >>

^*signifies non-member of ASH

901.O2.6 901. Health Services Research—Non-Malignant Conditions II